Envoy Medical Inc Warrant (COCHW)
Stock · NASDAQ · Health Care
$0.0362as of 10/14/2026
Price chart
Active signals
High Beta27.3%
Support level
$0.030185
Industry
Industrial Specialties
About COCHW
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; an…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 43
Fundamentals
- 1-day range
- Market cap
- $2.61M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 1.47
- Avg. volume
- —
52-week range
$0.02$0.095
Envoy Medical Inc Warrant Competitors
Chosen by industry and closest market cap.
- COCHWEnvoy Medical Inc Warrant$0.0362▲ 10.03%Market cap $2.61MP/E —$0.02$0.095
- BBLGBone Biologics Corp Common Stock$0.395▲ 1.80%Market cap $1.66MP/E —$0.3787$2.76
- FEEDENvue Medical Inc. Common Stock$0.371▼ 24.29%Market cap $3.67MP/E —$0.2001$79.43
- CLGNCollPlant Biotechnologies Ltd Ordinary Shares$3.63▼ 1.49%Market cap $6.25MP/E —$2.64$26.8
- HSCSHeartSciences Inc. Common Stock$3.02▼ 5.03%Market cap $7.80MP/E —$1.63$5.25
- CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares$1.9▼ 2.56%Market cap $8.98MP/E —$1.45$14.8
- FGIFGI Industries Ltd. Ordinary Shares$7.49▼ 0.27%Market cap $9.13MP/E —$3.14$19.93
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| COCHW Envoy Medical Inc Warrant | $2.61M | — | $0.0362 | ▲ 10.03% | $0.02$0.095 |
| BBLG Bone Biologics Corp Common Stock | $1.66M | — | $0.395 | ▲ 1.80% | $0.3787$2.76 |
| FEED ENvue Medical Inc. Common Stock | $3.67M | — | $0.371 | ▼ 24.29% | $0.2001$79.43 |
| CLGN CollPlant Biotechnologies Ltd Ordinary Shares | $6.25M | — | $3.63 | ▼ 1.49% | $2.64$26.8 |
| HSCS HeartSciences Inc. Common Stock | $7.80M | — | $3.02 | ▼ 5.03% | $1.63$5.25 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $8.98M | — | $1.9 | ▼ 2.56% | $1.45$14.8 |
| FGI FGI Industries Ltd. Ordinary Shares | $9.13M | — | $7.49 | ▼ 0.27% | $3.14$19.93 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 5.52M
- Total value held
- $409.7K
- Institutional holders
- 34
Top holders this quarter
- Unknown1.14M
- Unknown534.7K
- Unknown301.0K
- Unknown297.1K
- Unknown283.3K
- Unknown262.2K
- Unknown243.4K
- Unknown236.3K
- Unknown208.2K
- Unknown207.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Envoy Medical Submits Module for FDA Breakthrough Cochlear Implant
Envoy Medical has filed the second module of its modular pre‑market approval application for the Acclaim® cochlear implant, which has been granted FDA breakthrough status. The submission expands the data package that supports the device’s safety and effectiveness. This regulatory step could move the product closer to market availability. The filing follows the company’s earlier module and reflects ongoing progress toward FDA clearance.
Envoy Medical Submits Module for FDA Breakthrough Cochlear Implant. Envoy Medical has filed the second module of its modular pre‑market approval application for the Acclaim® cochlear implant, which has been granted FDA breakthrough status. The submission expands the data package that supports the device’s safety and effectiveness. This regulatory step could move the product closer to market availability. The filing follows the company’s earlier module and reflects ongoing progress toward FDA clearance.